Science & Enterprise subscription

Follow us on Twitter

  • A company designing treatments to restore the protective coating on nerve cells damaged by multiple sclerosis is co… https://t.co/wazhT6ZlRp
    about 13 hours ago
  • New post on Science and Enterprise: Genentech, Biotech Partner on Multiple Sclerosis https://t.co/0LVsKWN522 #Science #Business
    about 13 hours ago
  • New contributed post on Science and Enterprise: https://t.co/zBXBbIkYfN Careers Where Banter And Fun Come Into Their Own
    about 18 hours ago
  • A mobile and computer app that alerts older citizens about a class of drugs associated with Alzheimer's disease wil… https://t.co/ayTyKvff5T
    about 1 day ago
  • New post on Science and Enterprise: Trial to Test App Alerting for Dementia-Linked Drugs https://t.co/N6RksAetEY #Science #Business
    about 1 day ago

Please share Science & Enterprise

Trial Shows Immunotherapies Extend Life with Melanoma

T-cell lymphocyte

First results from a clinical trial show a combination of immunotherapies extends survival among patients with melanoma, but shorter periods for other solid-tumor cancers. . . . → Read More: Trial Shows Immunotherapies Extend Life with Melanoma

Crispr Enhanced for RNA Editing

Feng Zhang

Researchers expanded the ability of the genetic editing technique known as Crispr to alter the make-up of RNA, adding more ways to treat diseases. . . . → Read More: Crispr Enhanced for RNA Editing

Immunotherapy Biotech Gains $325M in Venture Funds

Investment graphic

A biotechnology enterprise developing personalized treatments for cancer and infectious diseases is raising $325 million in its second venture funding round. . . . → Read More: Immunotherapy Biotech Gains $325M in Venture Funds

Start-Up Creating Blood Tests, Apps for Mental Disorders

Blood sample tubes

A new enterprise based on psychiatric and molecular research at Indiana University is developing precision-medicine diagnostics for pain and mental disease. . . . → Read More: Start-Up Creating Blood Tests, Apps for Mental Disorders

Stem Cell Start-Up Raises $250M in Venture Funds

T-cell lymphocyte

A company begun last year to create cancer therapies from banked, off-the-shelf stem cells is raising $250 million in its first round of venture financing. . . . → Read More: Stem Cell Start-Up Raises $250M in Venture Funds

Artificial DNA Designed to Control Drug Delivery

DNA nanoparticle release

Researchers in Germany are developing techniques with artificial DNA and hydrogel designed to control the sequence of drugs delivered into the body. . . . → Read More: Artificial DNA Designed to Control Drug Delivery

Two Biotechs Each Issue $300M+ IPOs

NASDAQ share price display

Two biotechnology enterprises in the U.S. issued their initial public stock offerings yesterday, with each company raising at least $300 million in their transactions. . . . → Read More: Two Biotechs Each Issue $300M+ IPOs

Gut Microbe Linked to Longer Exercise Endurance

2014 Boston Marathon

An analysis of gut microbes from elite athletes identified a particular bacterial strain, which in tests with lab mice boosted their exercise endurance. . . . → Read More: Gut Microbe Linked to Longer Exercise Endurance

Intermountain, deCode Partner on Population Genetics

Kári Stefánsson

A health care network in Utah is partnering with a genetic analytics company to find connections between genetics and disease in 500,000 of its members. . . . → Read More: Intermountain, deCode Partner on Population Genetics

Patch Performs Fast DNA Collection for Plant Diseases

Microneedle plant patches

A small patch with tiny needles collects DNA from leaves in about one minute, making possible portable devices to detect plant diseases. . . . → Read More: Patch Performs Fast DNA Collection for Plant Diseases